Media Center

The ongoing Covid-19 pandemic has shone a spotlight on the vulnerability of the world in the face of a serious pandemic. On a human front, it has caused hundreds of thousands of deaths and has left people with life-changing disabilities and ongoing health problems. On an economic front, it has cost the globe multiple billions of dollars and has left people jobless and struggling to make ends meet.

Advanco, through this platform, ensures every product is given a unique barcode to indicate that it is legit through every step of its supply chain journey.

Regulatory compliance for serialization is increasingly becoming a focus area for pharmaceutical manufacturers and supply chain partners across the world. Therefore, as would be expected, advanco is already well-known and solidly established within the pharmaceutical sector.

Despite significant challenges caused by COVID-19 disruptions, the pharmaceutical track-and-trace sector has made strides in three areas to help secure the global supply chain now and well into the future.

The ongoing problem of counterfeit drugs has been brought to mainstream attention following the seizure of 3,000 saline-filled vials being sold as Covid-19 vaccines in China at the beginning of February 2021.

Pharmaceutical counterfeiting brought to the fore, as more than 3,000 saline filled vials being sold as COVID-19 vaccines were seized in Chinese police raids.

A strategic serialization partnership has been announced by advanco and Syntegon, aimed at tackling the global issue of counterfeit drugs.

Advanco, a Belgian IT company that has been automating pharma packaging plants for over 40 years, will now work with Syntegon (formerly, Bosch Packaging) on new or revamped serialization projects globally.

Advanco and Syntegon have announced a strategic partnership, marking a significant step towards helping to eradicate the growing problem of counterfeit drugs.

The partnership combines the strength of Advanco’s leading site manager system (ARC) with Syntegon’s machines for packaging pharmaceutical products and drugs

Advanco and Syntegon have announced a strategic partnership, marking a significant step towards helping to eradicate the growing problem of counterfeit drugs. The counterfeit drug market is estimated to exceed $75Bn and is once again in the spotlight as the world searches for a COVID-19 vaccine.

Track-and-trace provider advanco launches strategic serialization partnership with leading pharmaceutical packaging company Syntegon.

Parabellum Investments-backed Advanco and pharmaceutical packaging firm Syntegon have announced a serialization partnership to counter the growing harm of counterfeit drugs.

After the successful completion of a joint project, advanco IT and Services, Brussels and Syntegon Technology decided to increase cooperation by bringing the standards forward and creating benefits and convenience for serialization and aggregation demands.

Software product serialisation leader advanco plans international expansion

EPM speaks to Rami Cassis, executive chairman of pharmaceutical serialisation company Advanco and CEO of Parabellum Investments about the rise in counterfeit medicines during the Covid-19 pandemic.